An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
IDEXX Laboratories Schedules Two Institutional Investor Events
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
IDEXX Laboratories, Inc. (NASDAQ: IDXX) will participate in two upcoming institutional investor events. Jay Mazelsky, President and CEO, will join the Goldman Sachs Healthcare C-Suite Unscripted Conference in New York, New York on January 4, 2024, and will host an Investor and Analyst Session at VMX in Orlando, Florida on January 15, 2024, to highlight IDEXX’s new point of care analyzer.
Positive
None.
Negative
None.
WESTBROOK, Maine--(BUSINESS WIRE)--
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events:
Thursday, January 4, 2024, 1:30 pm EST - Jay Mazelsky, President and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference in New York, New York.
Monday, January 15, 2024, 1:00 pm EST - Jay Mazelsky and members of the IDEXX management team will host an Investor and Analyst Session at VMX in Orlando, Florida highlighting IDEXX’s new point of care analyzer. On-site participation is limited and advance registration for the in-person event is required; institutional investors and analysts interested in attending should contact investorrelations@idexx.com.
Individuals can access live audio webcasts of the fireside chat and VMX presentation through links on the IDEXX website, www.idexx.com/investors. Archived editions of the events will be available via the same links.
About IDEXX Laboratories
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.
What events will IDEXX Laboratories, Inc. (NASDAQ: IDXX) participate in?
IDEXX will join the Goldman Sachs Healthcare C-Suite Unscripted Conference in New York, New York on January 4, 2024, and will host an Investor and Analyst Session at VMX in Orlando, Florida on January 15, 2024.
Who will participate in the events?
Jay Mazelsky, President and CEO, will represent IDEXX at the events.
How can individuals access the events?
Live audio webcasts of the events will be available through links on the IDEXX website, www.idexx.com/investors.
Will archived editions of the events be available?
Yes, archived editions of the events will be accessible via the same links on the IDEXX website.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
